LIXT
NASDAQ · Biotechnology
Lixte Biotechnology Holdings
$3.82
+0.14 (+3.80%)
Open$3.73
Previous Close$3.68
Day High$4.01
Day Low$3.73
52W High$8.38
52W Low$2.36
Volume—
Avg Volume208.4K
Market Cap125.36M
P/E Ratio—
EPS$-1.10
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.59M | 2.67M | 2.41M |
| Net Income | 404.7K | 492.8K | 436.5K |
| Profit Margin | 15.6% | 18.4% | 18.1% |
| EBITDA | 711.7K | 711.0K | 701.7K |
| Free Cash Flow | 315.8K | 252.8K | 287.8K |
| Rev Growth | +13.7% | +15.1% | +4.1% |
| Debt/Equity | 1.15 | 1.36 | 1.30 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $263.29 | -1.12% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $423.64 | +1.32% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $151.28 | -0.61% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $526.73 | -0.18% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $750.51 | -0.23% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $254.07 | -0.51% | 41.4 | 33.44B |